Question 1

What are the main strengths of investing in N?

Accepted Answer

The main strengths of investing in Novartis include: Science-Based Climate Targets: SBTi-approved emissions reduction pathway with net-zero commitment by 2040, Water Stewardship: Pursuing water neutrality in operations by 2030 with comprehensive conservation programs, ESG Integration: Executive compensation tied to ESG targets and sustainability criteria embedded in supply contracts.

Question 2

What are the potential drawbacks of investing in N?

Accepted Answer

Potential drawbacks of investing in Novartis include: Pharmaceutical Access: Ongoing challenges in ensuring affordable access to medicines in developing markets, Clinical Trial Ethics: Managing complex ethical considerations in global clinical research operations, Supply Chain Complexity: Ensuring consistent ESG standards across extensive global pharmaceutical supply network.

Question 3

What are the key financial metrics for N?

Accepted Answer

Key financial metrics for Novartis include: Market Cap: $4.65 billion, Current Price: $270.63, Dividend Yield: 1.25%.

Novartis

Key Statistics

Valuation

Trading Info

52 Week

Dividends

Detailed View

N

ESG Ratings